
Melatonin Market Report 2026
Global Outlook – By Source Type (Natural Melatonin, Synthetic Melatonin), By Product Type (Tablets, Capsules, Liquid Solutions, Gummies, Sublingual Tablets), By Treatment Type (Dietary Supplements, Pharmaceuticals), By Application (Insomnia Treatment, Jet Lag Management, Sleep Disorders, Stress Relief, Circadian Rhythm Regulation ), By Distribution Channel (Online Retailers, Pharmacies, Health Food Stores, Supermarkets, Hypermarkets, Specialty Stores) - Market Size, Trends, And Global Forecast 2026-2035
Melatonin Market Overview
• Melatonin market size has reached to $2.03 billion in 2025 • Expected to grow to $2.99 billion in 2030 at a compound annual growth rate (CAGR) of 7.9% • Growth Driver: Rising Prevalence Of Insomnia Driving Market Growth Through Increasing Demand For Sleep Regulation Solutions • Market Trend: Innovative Multi-Phase Delivery Systems Enhancing Sleep Support And Efficacy • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.What Is Covered Under Melatonin Market?
Melatonin is a natural hormone produced by the pineal gland in the brain that helps regulate the body’s sleep-wake cycle, also known as the circadian rhythm. It is often used in supplement form to support sleep, especially for conditions such as insomnia or jet lag, by signaling to the body that it's time to rest. The main types of melatonin are natural and synthetic. Natural melatonin, a hormone produced by the pineal gland that regulates the sleep–wake cycle, can also be sourced from natural extracts for use in supplements. Melatonin products come in various formats, such as tablets, capsules, liquid solutions, gummies, and sublingual tablets, and treatment includes dietary supplements and, in some cases, pharmaceuticals. Melatonin is used to treat insomnia, manage jet lag, sleep disorders, reduce stress, and help regulate circadian rhythms. These products are widely distributed through online retailers, pharmacies, health food stores, supermarkets, hypermarkets, and specialty stores.
What Is The Melatonin Market Size and Share 2026?
The melatonin market size has grown strongly in recent years. It will grow from $2.03 billion in 2025 to $2.2 billion in 2026 at a compound annual growth rate (CAGR) of 8.3%. The growth in the historic period can be attributed to increasing prevalence of sleep disorders, rising stress and lifestyle imbalance, expansion of dietary supplement consumption, greater awareness of circadian rhythm health, availability of otc melatonin products.What Is The Melatonin Market Growth Forecast?
The melatonin market size is expected to see strong growth in the next few years. It will grow to $2.99 billion in 2030 at a compound annual growth rate (CAGR) of 7.9%. The growth in the forecast period can be attributed to increasing demand for personalized sleep solutions, rising focus on mental wellness, expansion of e-commerce supplement sales, growing acceptance of preventive healthcare, increasing research into sleep health. Major trends in the forecast period include increasing demand for natural sleep aids, rising adoption of otc sleep supplements, growing preference for non-habit forming solutions, expansion of multiple dosage formats, enhanced focus on circadian health.Global Melatonin Market Segmentation
1) By Source Type: Natural Melatonin, Synthetic Melatonin 2) By Product Type: Tablets, Capsules, Liquid Solutions, Gummies, Sublingual Tablets 3) By Treatment Type: Dietary Supplements, Pharmaceuticals 4) By Application: Insomnia Treatment, Jet Lag Management, Sleep Disorders, Stress Relief, Circadian Rhythm Regulation 5) By Distribution Channel: Online Retailers, Pharmacies, Health Food Stores, Supermarkets, Hypermarkets, Specialty Stores Subsegments: 1) By Natural Melatonin: Plant-Based Melatonin, Animal-Based Melatonin 2) By Synthetic Melatonin: Prescription-Based Synthetic Melatonin, Over-the-Counter (OTC) Synthetic MelatoninWhat Is The Driver Of The Melatonin Market?
The growing prevalence of insomnia is expected to propel the growth of the melatonin market going forward. Insomnia refers to a sleep disorder characterized by difficulty falling asleep, staying asleep, or waking up too early and not being able to fall back asleep, despite having the opportunity to sleep. Insomnia cases are rising due to the rising stress levels, excessive screen time, irregular sleep patterns, aging populations, and the growing incidence of chronic health conditions. Melatonin is useful for insomnia as it helps regulate the body’s sleep-wake cycle, making it easier to fall asleep and stay asleep, especially in cases of circadian rhythm disruptions. For instance, in April 2024, according to Oxford University Press, a UK-based publishing company, in 2024, approximately 19.5% of adult females and 14.0% of adult males in the Americas were affected by insomnia, totaling around 123 million people. Therefore, the growing prevalence of insomnia is driving the growth of the melatonin industry.Key Players In The Global Melatonin Market
Major companies operating in the melatonin market are Church and Dwight Co Inc, Herbalife Nutrition Ltd, Zenith Nutrition, Amway Corporation, Aurobindo Pharma, Aspen Holdings, Nu Skin Enterprises Inc, GNC Holdings LLC, Pharmavite LLC, Jamieson Wellness Inc, Rexall Sundown Inc, Natures Way Brands LLC, Schiff Nutrition International, Natrol LLC, Solgar Inc, Biotics Research Corporation, Herbaland Naturals Inc, Lactonova Nutripharm Pvt Ltd, Prime Health Ltd, Nestle Health Science, Bayer Consumer Health, Abbott NutritionGlobal Melatonin Market Trends and Insights
Major companies operating in the melatonin market are focusing on developing innovative technologies, such as three-in-one tablet in capsule technology, to enhance controlled release, improve absorption efficiency, and provide prolonged sleep support for better consumer outcomes. Three-in-one tablet-in-capsule technology combines three tablets within one capsule to release ingredients at different times, improving how the body absorbs them and making treatment more efficient and convenient. For instance, in September 2023, Ritual, a US-based wellness company, launched a new melatonin supplement featuring its innovative BioSeries technology, a three-phase release system within a single capsule, delivering melatonin in stages to align with the body's natural sleep-wake cycle. This approach enhances sleep quality by facilitating quicker sleep onset, maintaining restful sleep, and ensuring a refreshed feeling upon waking.What Are Latest Mergers And Acquisitions In The Melatonin Market?
In May 2023, Adalvo Limited, a Malta-based pharmaceutical company, partnered with EQL Pharma to broaden the global reach and commercialization of Mellozzan, a melatonin-based product. Through this collaboration, Adalvo will utilize its regulatory expertise and extensive distribution network spanning 89 countries while enabling EQL Pharma to focus on manufacturing and supply. EQL Pharma is a Sweden-based pharmaceutical company specializing in the development, marketing, and sale of generic and specialty medicines.Regional Outlook
North America was the largest region in the melatonin market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.What Defines the Melatonin Market?
The melatonin market consists of sales of patches, sprays, combination sleep aids, and lozenges. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.How is Market Value Defined and Measured?
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.What Key Data and Analysis Are Included in the Melatonin Market Report 2026?
The melatonin market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the melatonin industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.Melatonin Market Report Forecast Analysis
| Report Attribute | Details |
|---|---|
| Market Size Value In 2026 | $2.2 billion |
| Revenue Forecast In 2035 | $2.99 billion |
| Growth Rate | CAGR of 8.3% from 2026 to 2035 |
| Base Year For Estimation | 2025 |
| Actual Estimates/Historical Data | 2020-2025 |
| Forecast Period | 2026 - 2030 - 2035 |
| Market Representation | Revenue in USD Billion and CAGR from 2026 to 2035 |
| Segments Covered | Source Type, Product Type, Treatment Type, Application, Distribution Channel |
| Regional Scope | Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa |
| Country Scope | The countries covered in the report are Australia, Brazil, China, France, Germany, India, ... |
| Key Companies Profiled | Church and Dwight Co Inc, Herbalife Nutrition Ltd, Zenith Nutrition, Amway Corporation, Aurobindo Pharma, Aspen Holdings, Nu Skin Enterprises Inc, GNC Holdings LLC, Pharmavite LLC, Jamieson Wellness Inc, Rexall Sundown Inc, Natures Way Brands LLC, Schiff Nutrition International, Natrol LLC, Solgar Inc, Biotics Research Corporation, Herbaland Naturals Inc, Lactonova Nutripharm Pvt Ltd, Prime Health Ltd, Nestle Health Science, Bayer Consumer Health, Abbott Nutrition |
| Customization Scope | Request for Customization |
| Pricing And Purchase Options | Explore Purchase Options |
